Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ('Bluejay” or the 'Company”) announced that it has completed commercial-scale production of both polyclonal and monoclonal antibodies targeting interleukin-6 ...

PathoCare Holdings, Inc.—the parent company of medical diagnostics innovator PathoCare, LLC, a leader in Lab-on-a-Chip non-invasive Point-of-Care diagnostics—today announced that it has received a ...

Shareholders approved a reverse stock split range of 1-for-2 to 1-for-30 at a special meeting on December 5. ・Split-adjusted ...

As 2025 winds down, Mucar introduced a refreshed lineup of screen-equipped diagnostic devices, marking the second generation of its in-house hardware. Alongside the product launch, the company unveile ...

Paramount Business Jets reports that by 2030, many safety features in private aviation likely will shift from optional to ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved additional indications for its PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary ...

Researchers have developed a new compact Raman imaging system that is sensitive enough to differentiate between tumor and ...

PureHealth has unveiled its AI-powered Lab, a flagship AI-driven diagnostic facility developed under its subsidiary, PureLab.The 70,000-square-foot facility is set to transform national diagnostic ...

Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year survival rate of only five percent. Despite this poor prognosis, SCLC is initially highly responsive ...

Wilmington, Del.-based Nemours Children's shared plans in early December to open an institute for maternal-fetal health aimed at improving care ...

New York, NY, December 22nd, 2025, FinanceWireMedome is the first AI technology for Personal Health Records for ...